Zoetis Appoints Gavin D.K. Hattersley to its Board of Directors
- None.
- None.
Molson Coors’ President and Chief Executive Officer brings valuable business leadership and global public company experience to Zoetis Board
Mr. Hattersley brings global public company leadership and board experience, including as a current Chief Executive Officer and former Chief Financial Officer of Molson Coors, to the Zoetis Board. He will serve on the Board’s Corporate Governance and Sustainability Committee.
“Gavin Hattersley brings invaluable experience to our Board as we continue to expand in key markets around the globe,” said Kristin Peck, Chief Executive Officer of Zoetis. “His experience as CEO of a public company will help Zoetis as we continue to advance our vision to be the most trusted and valued animal health company, shaping the future of animal care through our innovation, customer obsession and purpose-driven colleagues.”
“We are pleased to welcome Gavin to Zoetis’ Board of Directors, and we look forward to the contributions he will make as we continue to advance Zoetis as the leader in animal health and deliver innovation for our customers and the animals in their care,” said Zoetis Board Chair Michael McCallister.
Mr. Hattersley has served as Molson Coors’ CEO since September 2019. Prior to his current position, Mr. Hattersley held various positions within the company including Chief Executive Officer of MillerCoors, the former
“I am incredibly grateful for the opportunity to join Zoetis’ Board of Directors at an exciting time for the company,” Hattersley said. “Zoetis’ mission to lead the industry with best-in-class animal care solutions, a diversified portfolio and a winning company culture matches perfectly with my professional experience and personal values, and I look forward to playing a role in Zoetis’ bright future.”
With Mr. Hattersley’s appointment, Zoetis increased the size of the Board from 12 to 13 members.
About Zoetis
As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers and ranchers. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of
ZTS-COR
ZTS-IR
View source version on businesswire.com: https://www.businesswire.com/news/home/20240401918431/en/
Media:
Jenielle Alonso
1-973-945-4333 (o)
jenielle.alonso@zoetis.com
Laura Panza
1-973-975-5176 (o)
laura.panza@zoetis.com
Investors:
Steve Frank
1-973-822-7141 (o)
steve.frank@zoetis.com
Nick Soonthornchai
1-973-443-2792 (o)
nick.soonthornchai@zoetis.com
Source: Zoetis Inc.
FAQ
Who was appointed to Zoetis' Board of Directors?
What is the ticker symbol for Zoetis Inc.?
What experience does Gavin D.K. Hattersley bring to Zoetis' Board?
How will Gavin D.K. Hattersley contribute to Zoetis' vision?